PepGen Inc. 8-K

What Happened
PepGen Inc. announced on May 21, 2026 that it updated its corporate presentation in connection with its participation in the 15th International Myotonic Dystrophy Consortium scheduled for May 26–30, 2026. The updated presentation is being furnished as Exhibit 99.1 to the Form 8-K. The company states the information is furnished under Regulation FD and “shall not be deemed ‘filed’” for purposes of Section 18 of the Exchange Act or incorporated by reference in other filings unless expressly stated.

Key Details

• Filing date: May 21, 2026.
• Event: 15th International Myotonic Dystrophy Consortium, May 26–30, 2026.
• Exhibit furnished: 99.1 — Corporate Presentation (updated as of May 2026).
• Disclosure status: Furnished under Regulation FD; not deemed “filed” under Section 18 and not automatically incorporated by reference.

Why It Matters
This 8-K lets investors know PepGen will present updated corporate materials at an upcoming scientific/industry conference. The furnished presentation may contain program, clinical or business updates important to evaluating the company’s pipeline and near-term milestones. The filing does not report earnings, management changes, mergers, or financial results — it simply makes the presentation available under Regulation FD, so investors should review Exhibit 99.1 for any substantive updates.